Characteristic | Hypoglycemia N of pts. = 2137 | Hyperglycemiaa N of pts. = 633 | ||||
---|---|---|---|---|---|---|
N (%) | % of total | P valueb | N (%) | % of total | P valueb | |
Gender |  |  | < 0.001 |  |  | < 0.001 |
 Female | 1018 (47.6) | 1.4 |  | 332 (52.4) | 0.5 |  |
 Male | 1119 (52.4) | 1.2 |  | 301 (47.6) | 0.3 |  |
Age class (years) |  |  | < 0.001 |  |  | < 0.001 |
  ≤ 44 years | 148 (6.9) | 1.7 |  | 89 (14.1) | 1.0 |  |
 45–54 | 147 (6.9) | 0.9 |  | 77 (12.2) | 0.5 |  |
 55–64 | 214 (10.0) | 0.7 |  | 95 (15.0) | 0.3 |  |
 65–74 | 427 (20.0) | 0.8 |  | 125 (19.7) | 0.2 |  |
  ≥ 75 | 1201 (56.2) | 2.0 |  | 247 (39.0) | 0.4 |  |
Deprivation index | Â | Â | 0.014 | Â | Â | 0.035 |
 I-II | 472 (22.1) | 1.2 |  | 140 (22.1) | 0.4 |  |
 III | 525 (24.6) | 1.2 |  | 144 (22.7) | 0.3 |  |
 IV-V | 1140 (53.3) | 1.3 |  | 349 (55.1) | 0.4 |  |
Number of comorbidities |  |  | < 0.001 |  |  | < 0.001 |
 None | 195 (9.1) | 0.9 |  | 87 (13.7) | 0.4 |  |
 One | 250 (11.7) | 0.7 |  | 92 (14.5) | 0.2 |  |
 Two or more | 1692 (79.2) | 1.6 |  | 454 (71.7) | 0.4 |  |
Chronic renal failure |  |  | < 0.001 |  |  | < 0.001 |
 No | 1814 (84.9) | 1.1 |  | 546 (86.3) | 0.3 |  |
 Yes | 323 (15.1) | 3.4 |  | 87 (13.7) | 0.9 |  |
Peripheral neuropathy |  |  | < 0.001 |  |  | < 0.001 |
 No | 1651 (77.3) | 1.2 |  | 459 (72.5) | 0.3 |  |
 Yes | 486 (22.7) | 1.8 |  | 174 (27.5) | 0.6 |  |
Hypoglycemia treatment |  |  | < 0.001 |  |  | < 0.001 |
 Insulin alone | 891 (41.7) | 4.1 |  | 232 (36.7) | 1.1 |  |
 Insulin and non-insulin anti-DM drugs | 607 (28.4) | 2.7 |  | 211 (33.3) | 1.0 |  |
 Anti-DM drugs at risk of hypoglycemia | 523 (24.5) | 1.0 |  | 116 (18.3) | 0.2 |  |
 Other non-insulin anti-DM drugs only | 116 (5.4) | 0.2 |  | 74 (11.7) | 0.1 |  |
Duration of insulin treatment |  |  | < 0.001 |  |  | < 0.001 |
 Less than 5 years | 572 (26.8) | 2.3 |  | 239 (37.8) | 1.0 |  |
 5 years or more | 926 (43.3) | 4.8 |  | 204 (32.2) | 1.1 |  |
 No insulin treatment | 639 (29.9) | 0.5 |  | 190 (30.0) | 0.2 |  |
ED attendance for hypoglycemia in 2014 |  |  | < 0.001 |  |  |  |
 No | 2056 (96.2) | 1.2 |  |  |  |  |
 Yes | 81 (3.8) | 17.3 |  |  |  |  |
ED attendance for hyperglycemia in 2014 |  |  |  |  |  | < 0.001 |
 No |  |  |  | 617 (97.5) | 0.4 |  |
 Yes |  |  |  | 16 (2.5) | 6.6 |  |
Glycated hemoglobin test |  |  | 0.65 |  |  | < 0.001 |
 No | 842 (39.4) | 1.3 |  | 303 (47.9) | 0.5 |  |
 Yes | 1295 (60.6) | 1.3 |  | 330 (52.1) | 0.3 |  |
Adequate number of glucose test strips |  |  | < 0.001 |  |  | 0.79 |
 No | 1026 (48.0) | 1.1 |  | 366 (57.8) | 0.4 |  |
 Yes | 1111 (52.0) | 1.5 |  | 267 (42.2) | 0.4 |  |